AM

Ashok Monga

Active Director Whole-Time Director DIN 00776287
DIN 00776287 First appointment Dec 1993 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 3 historical roles
Total affiliations 8 Since Dec 1993
Shareholding value •••• Premium profile

About Ashok Monga

Data last updated:

Ashok Monga is a Whole-Time Director at Rhydburg Pharmaceuticals Ltd (since 1993), Director at Genedrift Global Services Private Limited (since 2025) and Designated Partner at Genedrift Solutions Llp (since 2025), and holds 2 more current directorships. The companies operate in Pharma, Business Services and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹49.39 Cr; the largest is Rhydburg Pharmaceuticals Ltd at ₹48.17 Cr (FY 2024). Earlier, Ashok Monga was a Director at Alba Polymers Limited (2014–2015) and Director at Dezzle Pharma Private Limited (from 2012) and 1 more.

DIN 00776287
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 15 Dec 1993
Oldest Company Age 39 yrs
Largest company Rhydburg Pharmaceuticals Ltd · ₹48.17 Cr (FY 2024)
Combined revenue ₹49.39 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhydburg Pharmaceuticals Ltd U24231DL1987PLC028434
Whole-Time Director15 Dec 19931987₹48.17 Cr (FY 2024)Active
Director14 Aug 20252022₹1.22 Cr (FY 2024)Active
Designated Partner14 Aug 20252019Active
Designated Partner20 Apr 20152015Active
Designated Partner27 Feb 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alba Polymers Limited L74899DL1995PLC066652
Director27 Sep 20141995₹35.4 Lakh (FY 2022)Active
Dezzle Pharma Private Limited U51397DL1998PTC096946
Director12 Oct 20121998Converted To Llp
Director20 Jun 19971997Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rhydburg Pharmaceuticals Ltd
Dezzle Pharma Private Limited
Seema Monga's Curls And Curves Pvt Ltd
Dezzle Pharma Llp
Premium access

Shareholding and investment profile for Ashok Monga

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Monga

Ashok Monga currently holds 5 directorships: Rhydburg Pharmaceuticals Ltd (Whole-Time Director, since 15 Dec 1993, revenue ₹48.17 Cr (FY 2024)); Genedrift Global Services Private Limited (Director, since 14 Aug 2025, revenue ₹1.22 Cr (FY 2024)); Genedrift Solutions Llp (Designated Partner, since 14 Aug 2025); Seema Monga's Curls And Curves Llp (Designated Partner, since 20 Apr 2015); Dezzle Pharma Llp (Designated Partner, since 27 Feb 2015).

Ashok Monga was first appointed on 15 Dec 1993 as Whole-Time Director at Rhydburg Pharmaceuticals Ltd. The most recent appointment on record is 14 Aug 2025 at Genedrift Solutions Llp.

The 2 current companies of Ashok Monga that report revenue have a combined latest revenue of ₹49.39 Cr: Rhydburg Pharmaceuticals Ltd ₹48.17 Cr (FY 2024); Genedrift Global Services Private Limited ₹1.22 Cr (FY 2024).

Ashok Monga held 3 earlier board appointments: Alba Polymers Limited (Director, 27 Sep 2014 to 28 Jan 2015); Dezzle Pharma Private Limited (Director, from 12 Oct 2012); Seema Monga's Curls And Curves Pvt Ltd (Director, from 20 Jun 1997).

The current boards of Ashok Monga's companies include Seema Monga (Rhydburg Pharmaceuticals Ltd), Sovan Lal Subalchand Pal (Rhydburg Pharmaceuticals Ltd), Vinod Thapar (Rhydburg Pharmaceuticals Ltd), Akshay Monga (Genedrift Global Services Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available